Recent Research Analysts’ Ratings Updates for IMAX (IMAX)

IMAX (NYSE: IMAX) has recently received a number of price target changes and ratings updates: 1/18/2024 – IMAX had its price target lowered by analysts at Benchmark Co. from $24.00 to $22.00. They now have a “buy” rating on the stock. 1/11/2024 – IMAX had its price target lowered by analysts at The Goldman Sachs […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Increases Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $92.00
Next post Research Analysts Issue Forecasts for Cargojet Inc.’s FY2024 Earnings (TSE:CJT)